Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis
- 15 May 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (10) , 5878-5881
Abstract
The ability of various infections to suppress neoplastic growth has been well documented. This phenomenon has been traditionally attributed to infection-induced concomitant, cell-mediated antitumor immunity. We found that infection with Toxoplasma gondii effectively blocked neoplastic growth of a nonimmunogenic B16.F10 melanoma. Moreover, this effect was independent of cytotoxic T or NK cells, production of NO by macrophages, or the function of the cytokines IL-12 and TNF-α. These findings suggested that antitumor cytotoxicity was not the primary mechanism of resistance. However, infection was accompanied by strong, systemic suppression of angiogenesis, both in a model system and inside the nascent tumor. This suppression resulted in severe hypoxia and avascular necrosis that are incompatible with progressive neoplastic growth. Our results identify the suppression of tumor neovascularization as a novel mechanism critical for infection-induced resistance to tumors.Keywords
This publication has 30 references indexed in Scilit:
- Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.Journal of Clinical Investigation, 1998
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- Angiogenesis and metastasisEuropean Journal of Cancer, 1996
- IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine ResponsesImmunity, 1996
- Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of AngiogenesisBiochemical and Biophysical Research Communications, 1995
- Inhibition of Angiogenesis In Vivo by Interleukin 12JNCI: Journal of the National Cancer Institute, 1995
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Macrophage tumoricidal mechanismsResearch in Immunology, 1993
- The ClassicClinical Orthopaedics and Related Research, 1991
- Resistance to a non-immunogenic tumor, induced byCorynebacterium parvum orListeria monocytogenes, is abrogated by anti-interferonγInternational Journal of Cancer, 1990